PWR
56
-4
HST
45
-7
KEY
37
-3
CINF
31
-14
MO
63
12
BMY
41
8
ETR
72
17
KMI
69
-4
ABBV
62
3
PFG
37
-3
HCA
50
2
TXT
50
-3
EBAY
33
-6
EFX
35
-3
AMP
64
-2
ADSK
61
-2
IVZ
46
-6
CNX
69
-4
KIM
63
-3
CMA
55
-3
PWR
56
-4
HST
45
-7
KEY
37
-3
CINF
31
-14
MO
63
12
BMY
41
8
ETR
72
17
KMI
69
-4
ABBV
62
3
PFG
37
-3
HCA
50
2
TXT
50
-3
EBAY
33
-6
EFX
35
-3
AMP
64
-2
ADSK
61
-2
IVZ
46
-6
CNX
69
-4
KIM
63
-3
CMA
55
-3
Financhill
Back

Astellas Pharma Quote, Financials, Valuation and Earnings

AI DIVIDENDS: No. 1 Way to Collect Passive Income

Click here to get it for free.
Buy
51

ALPMY
Astellas Pharma

Last Price:
11.68
Seasonality Move:
0.97%

7 Day Trial

ALL ACCESS PASS

$ 7

How To Collect Up To 69% Yields From ZERO-Dividend Stocks

Click HERE to learn how to potentially collect $84,160 per year.

Astellas Pharma Price Quote

$11.68

Astellas Pharma Key Stats

Buy
51
Astellas Pharma (ALPMY) is a Buy
Day range:
$11.26 - $12.00
52-week range:
$9.15 - $13.14
Dividend yield:
3.94%
P/E ratio:
177.98
P/S ratio:
1.84
P/B ratio:
1.98%
Volume:
44.5K
Avg. volume:
73.4K
1-year change:
-7.96%
Market cap:
$20.9B
Revenue:
$11.1B
EPS:
$0.06

How Much Does Astellas Pharma Make?

Is Astellas Pharma Growing As A Company?

  • What Is Astellas Pharma's Growth Rate Quarterly?
    Quarterly YoY revenue growth is 0.11%
  • What Is Astellas Pharma's EPS Quarterly YoY Growth Rate?
    Quarterly, year-over-year diluted EPS growth rate is 0%

Astellas Pharma Stock Price Performance

  • Did Astellas Pharma Stock Go Up Last Month?
    Astellas Pharma share price went up by 2.01% last month
  • Did ALPMY's Share Price Rise Over The Last Year?
    ALPMY share price fell by -7.96% over the past 1 year

What Is Astellas Pharma 52-Week High & Low?

Astellas Pharma Price To Free Cash Flow

Data Unavailable

Is It Risky To Buy Astellas Pharma?

  • How Much Debt Does Astellas Pharma Have?
    Total long term debt quarterly is $0
  • How Much Cash Does Astellas Pharma Have?
    Cash and short term investments quarterly total is $2.4B
  • What Is Astellas Pharma’s Book Value Per Share?
    Book value per share is 5.88

Is Astellas Pharma Cash Flow Positive?

  • What Is ALPMY Cash Flow From Operations?
    Cash flow from operations (TTM) is $1.2B
  • What Is Astellas Pharma’s Cash Flow From Financing?
    Cash flow from financing (TTM) is $4.3B
  • What Is Astellas Pharma’s Cash Flow From Investing?
    Cash flow from investing (TTM) is -$5.9B

Astellas Pharma Return On Invested Capital

  • Is Management Doing A Good Job?
    ALPMY return on invested capital is 0.66%
  • What Is Astellas Pharma Return On Assets?
    ROA measures how assets are converting to revenues and is 0.47%
  • What Is ALPMY Return On Equity?
    ROE is a measure of profitability and is 0.97%

Astellas Pharma Earnings Date & Stock Price

Astellas Pharma Competitors

Astellas Pharma Dividend Yield

Astellas Pharma Analyst Estimates

YoY Growth Past Surprise
EPS: 0.07% 0%
Revenue: 11.06% 0%

Analyst Recommendations

Buy Recommendations: 0
Hold Recommendations: 0
Sell Recommendations: 0
Price Target: 0.00
Downside from Last Price: -100%

Major Shareholders

  • How many ALPMY shares are owned by institutional investors?
    1M ALPMY shares are owned by institutional investors
  • How many ALPMY shares are owned by insiders?
    0 ALPMY shares are owned by insiders